Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9071|90|3|490-496

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.90, Iss.3, 2018-03, pp. : 490-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of the Globular Heads of C1q Receptor (gC1qR) Gene in Regulating Apoptosis of Human Cervical Squamous Cell Carcinoma

By  

Cellular Physiology and Biochemistry, Vol. 30, Iss. 5, 2012-10 ,pp. : 1181-1190

Karger

Access to resources Recommend Favorite

Hepatitis C Virus and Hepatocellular Carcinoma

By Kanda Tatsuo   Yokosuka Osamu   Omata Masao  

Biology, Vol. 2, Iss. 1, 2013-01 ,pp. : 304-316

MDPI

Access to resources Recommend Favorite

Association of the interleukin18 137 C/G, 607 A/C polymorphisms with type 1 diabetes: A metaanalysis

By            

Biomedical Reports, Vol. 2, Iss. 1, 2014-01 ,pp. : 57-62

Spandidos Publications

Access to resources Recommend Favorite

Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma

By            

Biomedical Reports, Vol. 1, Iss. 5, 2013-01 ,pp. : 771-775

Spandidos Publications

Access to resources Recommend Favorite

Association of genetic variants in the interleukin‐18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection

By  

IUBMB LIFE, Vol. 70, Iss. 2, 2018-02 ,pp. : 165-174

John Wiley & Sons Inc

Access to resources Recommend Favorite